文献速递间质性肺疾病

纤维化间质性肺疾病患者的氧疗:国际德尔菲调查

Oxygen in patients with fibrotic interstitial lung disease: an international Delphi survey.
PubMed 文献 · Eur Respir J · 2019-08-08

该国际德尔菲调查旨在就纤维化间质性肺疾病患者补充氧疗的适应症与目标达成专家共识,并识别获取障碍。45名专家中42名(93%)完成三轮调查,代表17个国家。36个条目中20个达成共识,专家同意对严重静息低氧血症及运动后血氧饱和度降至<85-89%且伴症状或运动受限者推荐氧疗,但氧疗资金覆盖存在地区差异。

要点

  • 专家共识推荐严重静息低氧血症患者应接受氧疗。
  • 运动后SpO2降至<85-89%且伴症状或运动受限时推荐氧疗。
  • 氧疗资金覆盖因地区、阈值和症状要求而异。

核心结论

  • 专家在20个条目上达成共识,指导纤维化ILD的补充氧疗使用。
  • 共识可用于指导研究、临床推荐和资金政策。

研究设计与样本

  • 国际德尔菲调查,基于半结构化访谈和文献检索形成条目。
  • 45名专家中42名(93%)完成全部三轮调查,代表17个国家。

主要发现

  • 36个条目中20个达成同意或不同意共识,10个达成不确定共识,4个未达成共识。
  • 专家同意严重静息低氧血症和运动后SpO2<85-89%伴症状或运动受限时推荐氧疗。
  • 氧疗资金覆盖基于血氧饱和度阈值、临床症状和检测要求存在地区差异。

关键数值与推荐

  • 共识定义:同意为得分中位数4(同意)至5(强烈同意),不同意为1(强烈不同意)至2(不同意),不确定为3(不确定)且四分位距0-1。
  • 推荐氧疗指征包括严重静息低氧血症和运动后SpO2降至<85-89%尤其伴症状或运动受限。

临床怎么用

  • 临床可参考专家共识对纤维化ILD患者评估静息和运动后低氧血症并考虑氧疗。
  • 需注意地区资金覆盖差异对氧疗可及性的影响。

局限性

  • 共识基于专家意见,证据水平有限。
  • 资金覆盖差异可能影响共识的普适性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

RATIONALE: Patients with fibrotic interstitial lung disease (ILD) frequently develop resting or exertional hypoxaemia. There is heterogeneity in clinical practice and a paucity of evidence guiding supplemental oxygen use in this patient population. The objectives of this study were to build international expert-based consensus on the indications and goals of supplemental oxygen from the perspective of healthcare providers, and identify potential barriers to its access. METHODS: Semistructured interviews and a comprehensive literature search informed items for the Delphi survey, with items not meeting consensus included in round 2. Round 3 contained survey questions regarding regional funding coverage for oxygen therapy. A priori definitions of consensus were median scores of 4 (agree) to 5 (strongly agree) for "agreement", 1 (strongly disagree) to 2 (disagree) for "disagreement" or 3 (unsure) with an interquartile range of 0-1. RESULTS: 42 out of 45 (93%) experts completed all three survey rounds, representing 17 countries. 20 out of 36 items met consensus for agreement or disagreement, 10 items met consensus for unsure and four items did not meet consensus. Experts agreed that oxygen should be recommended for patients with severe resting hypoxaemia and in cases of exertional desaturation to <85-89%, particularly with attributable symptoms or exercise limitation. There are regional differences in funding coverage for oxygen, based on desaturation thresholds, clinical symptoms and testing requirements. CONCLUSIONS: Experts achieved consensus on 20 items guiding supplemental oxygen use in fibrotic ILD. These findings may inform research, clinical recommendations and funding policy.

来源:Eur Respir J,查看原文。版权归原作者所有。

引用

  1. Lim RK, Humphreys C, Morisset J, et al. Oxygen in patients with fibrotic interstitial lung disease: an international Delphi survey. Eur Respir J. 2019. PMID: 31097522. doi:10.1183/13993003.00421-2019

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。